Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer
Oncology Research · 2026
DOI: 10.32604/or.2026.075028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Benjamin Heckelmann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, Lübeck, Germany. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Precision Medicine, Carcinoma, Pancreatic Ductal, Antineoplastic Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, Lübeck, Germany.
Zitieren
APA
Heckelmann, B., Duhn, J., & Braun, R. (2026). Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer. Oncology Research. https://doi.org/10.32604/or.2026.075028
Vancouver
Heckelmann B, Duhn J, Braun R. Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer. Oncology Research. 2026. doi:10.32604/or.2026.075028
BibTeX
@article{Heckelmann2026,
author = {Heckelmann, Benjamin and Duhn, Jannis and Braun, Rüdiger},
title = {Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.075028}
}
EUVIMED